NLRP3

Chr 1AD

NLR family pyrin domain containing 3

Also known as: AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS

This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]

GeneReviewsOMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

CINCA syndromeMIM #607115
AD
Deafness, autosomal dominant 34, with or without inflammationMIM #617772
AD
Familial cold inflammatory syndrome 1MIM #120100
AD
Keratoendothelitis fugax hereditariaMIM #148200
AD
Muckle-Wells syndromeMIM #191900
AD
UniProtFamilial cold autoinflammatory syndrome 1
UniProtChronic infantile neurologic cutaneous and articular syndrome

Clinical highlights

Interpreting a novel variant
Gain of function is the curated mechanism (Gene2Phenotype), so a variant that simply removes the protein may not be the pathogenic class here — missense variants in functional domains often carry more weight.Curated gene-level mechanism — a prior for triage, not a per-variant call.
12
Active trials
8133
Pubs (1 yr)
P/LP submissions
P/LP missense
0.52
LOEUF
GOF*
Mechanism· G2P
📖
GeneReview available — NLRP3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.52LOEUF
pLI 0.001
Z-score 3.94
OE 0.33 (0.210.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.14Z-score
OE missense 0.74 (0.690.81)
414 obs / 556.1 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.33 (0.210.52)
00.351.4
Missense OE?0.74 (0.690.81)
00.61.4
Synonymous OE?1.28
01.21.6
LoF obs/exp: 13 / 39.8Missense obs/exp: 414 / 556.1Syn Z: -3.41

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

NLRP3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Critical Illness Myopathy

NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness

RECRUITING
NCT07017517Phase NAUniversity of ChileStarted 2026-04-20
Motomed Letto® servo-assisted cycling + standard physiotherapyStandard physiotherapy
PeriodontitisGingivitisPeriodontal Diseases

Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis

ACTIVE NOT RECRUITING
NCT07563192Suleyman Demirel UniversityStarted 2024-10-15
Leishmaniasis

Mediterranean Visceral Leishmaniasis With Leishmania Infantum

ACTIVE NOT RECRUITING
NCT03784248Centre Hospitalier Universitaire de NiceStarted 2019-07-03
blood donation and isolation of leuco-platelet layers
Clonal HematopoiesisClonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance (CCUS)

CHIP in Health and Disease

NOT YET RECRUITING
NCT07780552VASCage GmbHStarted 2026-10
Obstructive Sleep Apnea-Hypopnea SyndromeAnxiety DisordersDepressive Disorders

EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders

RECRUITING
NCT07120711Xinhua Hospital, Shanghai Jiao Tong University School of MedicineStarted 2025-07-01
EGR2/NLRP3 pathway activityfatty tissue
Type 2 DiabetesInflammationInsulin Sensitivity/Resistance

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

RECRUITING
NCT04485871Phase NAInstitut de Recherches Cliniques de MontrealStarted 2019-12-19
Omega-3 fatty acids
Transgender Individuals

Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.

NOT YET RECRUITING
NCT07394400Milagros Rocha BarajasStarted 2026-02-14
Vitiligo

TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients

ACTIVE NOT RECRUITING
NCT07232238Aswan UniversityStarted 2025-10-20
NOMIDDIRANLRC4-MAS

Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

RECRUITING
NCT02974595National Institute of Allergy and Infectious Diseases (NIAID)Started 2016-12-09
Chronic Kidney FailureFrailtyAging

Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation

NOT YET RECRUITING
NCT06887075Phase NAUniversity Hospital, BordeauxStarted 2025-04-15
Blood sampleGeriatric assessment standardized
Type 2 DiabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Prediabetes / Type 2 Diabetes

Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

NOT YET RECRUITING
NCT07575438Phase PHASE2May Faraj, PDt, PhDStarted 2026-07
Fish OilFish OilCorn oil control
Heart Failure, SystolicHeart Failure NYHA Class IVMetabolic Disturbance

Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure

ACTIVE NOT RECRUITING
NCT04528004Phase EARLY_PHASE1University of WashingtonStarted 2020-09-26
Nicotinamide ribosidePlacebo